A large preclinical toxicity program run across mice, rats, rabbits, and dogs found BPC-157 well tolerated with no serious treatment-related toxicity, no identifiable lethal dose, and no genotoxic or teratogenic signal, which is the strongest safety data point available by Xu 2020
One milligram per millilitre equals 1,000 micrograms per millilitre
( in vitro)
Berberine activates AMPK through a different mechanism than MOTS-c (via inhibition of complex I in mitochondria), so concurrent use may create additive rather than synergistic AMPK activationhigher risk of hypoglycemia without proportional metabolic benefit
Benefits build over time
Certain peptides, like BPC-157, can cross the blood-brain barrier when administered nasally, allowing them to interact with neurotransmitters and reduce inflammation in the nervous system